» Articles » PMID: 20437048

Optimizing the Protocol for Pulmonary Cryoablation: a Comparison of a Dual- and Triple-freeze Protocol

Overview
Date 2010 May 4
PMID 20437048
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to compare a double freeze-thaw protocol to a triple freeze-thaw protocol for pulmonary cryoablation utilizing an in vivo porcine lung model. A total of 18 cryoablations were performed in normal porcine lung utilizing percutaneous technique with 9 each in a double- (10-5-10) and triple-freeze (3-3-7-7-5) protocol. Serial noncontrast CT images were obtained during the ablation. CT imaging findings and pathology were reviewed. No imaging changes were identified during the initial freeze cycle with either protocol. However, during the first thaw cycle, a region of ground glass opacity developed around the probe with both protocols. Because the initial freeze was shorter with the triple freeze-thaw protocol, the imaging findings were apparent sooner with this protocol (6 vs. 13 min). Also, despite a shorter total freeze time (15 vs. 20 min), the ablation zone identified with the triple freeze-thaw protocol was not significantly different from the double freeze-thaw protocol (mean diameter: 1.67 ± 0.41 cm vs. 1.66 ± 0.21 cm, P = 0.77; area: 2.1 ± 0.48 cm(2) vs. 1.99 ± 0.62 cm(2), P = 0.7; and circularity: 0.95 ± 0.04 vs. 0.96 ± 0.03, P = 0.62, respectively). This study suggests that there may be several advantages of a triple freeze-thaw protocol for pulmonary cryoablation, including earlier identification of the imaging findings associated with the ablation, the promise of a shorter procedure time or larger zones of ablation, and theoretically, more effective cytotoxicity related to the additional freeze-thaw cycle.

Citing Articles

Percutaneous Cryoablation of Non-small Cell Lung Cancer in Patients with Recurrence After Stereotactic Body Radiation Therapy.

Fish A, Park H, Knight E, Knowlton C, Madoff D Cardiovasc Intervent Radiol. 2025; .

PMID: 40069339 DOI: 10.1007/s00270-025-04002-0.


Review on endobronchial therapies-current status and future.

Chan J, Siu I, Chang A, Li M, Lau R, Mok T Ann Transl Med. 2024; 12(4):75.

PMID: 39118957 PMC: 11304415. DOI: 10.21037/atm-23-1430.


Transbronchial cryoablation in peripheral lung parenchyma with a novel thin cryoprobe and initial clinical testing.

Gu C, Yuan H, Yang C, Xie F, Chen J, Zhu L Thorax. 2024; 79(7):633-643.

PMID: 38242710 PMC: 11187365. DOI: 10.1136/thorax-2023-220227.


CT-Guided Percutaneous Cryoablation for Lung Metastasis of Colorectal Cancer: A Case Series.

Wang F, Luo R, Tian J, Liu H, Yang J Technol Cancer Res Treat. 2023; 22:15330338231201508.

PMID: 37735896 PMC: 10515520. DOI: 10.1177/15330338231201508.


Cryoablation and immunity in non-small cell lung cancer: a new era of cryo-immunotherapy.

Velez A, DeMaio A, Sterman D Front Immunol. 2023; 14:1203539.

PMID: 37671163 PMC: 10475831. DOI: 10.3389/fimmu.2023.1203539.


References
1.
Gage A, Baust J . Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998; 37(3):171-86. DOI: 10.1006/cryo.1998.2115. View

2.
Littrup P, Ahmed A, Aoun H, Noujaim D, Harb T, Nakat S . CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol. 2007; 18(3):383-92. DOI: 10.1016/j.jvir.2006.12.007. View

3.
Ahmed A, Littrup P . Percutaneous cryotherapy of the thorax: safety considerations for complex cases. AJR Am J Roentgenol. 2006; 186(6):1703-6. DOI: 10.2214/AJR.04.1068. View

4.
Wang H, Littrup P, Duan Y, Zhang Y, Feng H, Nie Z . Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005; 235(1):289-98. DOI: 10.1148/radiol.2351030747. View

5.
Simon C, Dupuy D, DiPetrillo T, Safran H, Grieco C, Ng T . Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007; 243(1):268-75. DOI: 10.1148/radiol.2431060088. View